Skip to main content
. 2016 Aug 27;23(3):217–230. doi: 10.1007/s40292-016-0155-2

Fig. 3.

Fig. 3

Mean percent change from baseline in LDL-C levels in patients atorvastatin with or without alirocumab.

Reproduced with permission from Roth et al. [42]